 Germ-Chemo Combo Fights CancerBacteria that can cause deadly infections in humans and animals have shown promise in treating cancer by "eating" tumors from the inside out. Now, two new studies at the Johns Hopkins Kimmel Cancer Center have demonstrated that, combined with specially-packaged anti-cancer drugs, the bacterial therapy's prospects for cancer eradication have dramatically improved.
 "Erectile Dysfunction" Drugs Heighten Natural Anti-Cancer ActivitySildenafil and other "impotence drugs" that boost the production of a gassy chemical messenger to dilate blood vessels and produce an erection now also show promise in unmasking cancer cells so that the immune system can recognize and attack them, say scientists at the Johns Hopkins Kimmel Cancer Center.
 Chemotherapy and Radiation After Pancreatic Cancer Surgery Boosts SurvivalCombined chemotherapy and radiation after surgery for pancreatic cancer increases a patient's chance of living longer, according to a Johns Hopkins study presented in November at the American Society for Therapeutic Radiology and Oncology annual meeting. Radiation oncologists Joseph Herman, M.D., and Michael Swartz, M.D., reviewed records from the past 12 years of 156 patients that received their surgery followed by chemotherapy and radiation therapy at Johns Hopkins Hospital. They compared their survival to 406 patients who had surgery only.
 David Koch Gives $20 Million for Hopkins Cancer ResearchDavid H. Koch, philanthropist and executive vice president of the nation's largest privately owned company, Koch Industries, Inc., has committed $20 million to support a new cancer research building on Johns Hopkins University's East Baltimore medical campus. The building was named the David H. Koch Cancer Research Building in his honor at a dedication ceremony on December 4, 2006.
|
